Adverum Biotechnologies, Inc. (ADVM) NASDAQ

4.36

+0(+0.00%)

Updated at December 09, 2025 04:00PM

Currency In USD

Valuation

Market Cap92.38M
Enterprise Value123.43M
P/E Ratio-0.5
PEG Ratio0.05
Price/Sales Ratio0
Price/Book Ratio-1.84
Enterprise/Revenue0
Enterprise/EBITDA-0.77

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-2.82
Return On Equity-38.45

Income Statement

Revenue1M
Revenue/Share0
Gross Profit1M
EBITDA-135.51M
Net Income-130.93M
Diluted EPS-6.62

Balance Sheet

Total Cash26.06M
Total Cash/Share1.11
Total Debt88.94M
Total Debt/Equity-1.6
Current Ratio0.65
Book Value Per Share-2.37

Price History

52-Week Change-3.54
52-Week High6.07
52-Week Low1.78
Moving Average 50 Days4.41
Moving Average 200 Days3.48

Statistics

Average Volume724,344
Shares Outstanding22.08M
% Held by Institutions54.68

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateMarch 21, 2024